Upgrade to SI Premium - Free Trial

Zimmer Biomet (ZBH) PT Raised to $138 at Baird on 4Q Report; 'Revenues Shows Signs of Stabilization'

January 31, 2018 8:18 AM
Baird raised its price target on Zimmer Biomet (NYSE: ZBH) to $138.00 (from $130.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles